Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system

Hum Reprod. 2006 May;21(5):1129-34. doi: 10.1093/humrep/dei476. Epub 2006 Jan 25.

Abstract

Objective: The objective was to assess endometrial chemokines in users of the levonorgestrel-releasing intrauterine system (LNG-IUS) and correlate them with leucocyte populations, uterine natural killer cells (uNK) and mast cells (MCs).

Materials and methods: Endometrium was obtained from two groups of women who had been using LNG-IUS for 3 years or more: 11 amenorrhoeic women formed the non-bleeding group and 15 women who maintained some form of cyclic bleeding comprised the bleeding group. Specific antibodies were used for the assessment of neutrophils, uNK cells and MCs. Immunohistochemistry was performed to locate the chemokines 6Ckine and interleukin-8 (IL-8).

Results: Neutrophils were few and without differences between the two groups. uNK cells were significantly higher in the bleeding group (P < 0.0001). There was no difference between the total number of MCs and activated MCs, but there was a greater extracellular area stained for MC tryptase (P < 0.05). Chemokines 6CKine and IL-8 were abundant in the stroma and in the epithelium, and there was no difference between the groups.

Conclusions: We observed more uNK cells in users with bleeding and a greater extracellular area stained for MC tryptase, although there were no differences between the number of MCs and activated MCs or the chemokines 6CKine and IL-8. uNK cells and MC products may play a role in provoking breakthrough bleeding in long-term users of the LNG-IUS.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokines / analysis
  • Chemokines / metabolism
  • Contraceptive Agents, Female / administration & dosage
  • Contraceptive Agents, Female / adverse effects*
  • Endometrium / chemistry
  • Endometrium / drug effects
  • Endometrium / immunology*
  • Female
  • Humans
  • Immunochemistry
  • Intrauterine Devices, Medicated / adverse effects*
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / immunology
  • Levonorgestrel / administration & dosage
  • Levonorgestrel / adverse effects*
  • Mast Cells / cytology
  • Mast Cells / immunology
  • Metrorrhagia / chemically induced
  • Metrorrhagia / immunology*

Substances

  • Chemokines
  • Contraceptive Agents, Female
  • Levonorgestrel